A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Radavirsen (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 20 Sep 2017 Results published in the British Journal of Clinical Pharmacology
- 30 Jun 2016 Status changed from active, no longer recruiting to completed.
- 30 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.